Search for content and authors
 

Fluoride effects on oxygen consumption and oxidative stress

Brenda L. Fina ,  Mercedes Lombarte ,  Eugenia R. Da Ros ,  Nicolas Rigalli ,  Alfredo Rigalli 

Bone Biology Laboratory, School of Medicine, Rosario National University (UNR), Santa Fe 3100, Rosario 2000, Argentina

Abstract

Fluoride (F) increases bone mass but the presence of inflammation has been observed in F treatments in rats. The lack of effectiveness of F as an anti-osteoporotic drug could be due to inflammation. Inflammation could be the consequence of an increase in reactive oxygen species (ROS), as a result of modifications of the respiratory chain activity. The aim of this work was to evaluate the effect of F on the oxygen uptake rate (VO2) in rats treated with sodium fluoride (NaF). Eighteen Sprague-Dawley rats were divided into 3 groups (n=6 per group): NaF20, NaF40, which received orally 20 or 40 µmol NaF/100g bw.day for 30 days; and Controls that received water. VO2 and fluoremia were measured in vivo before and after 90 min of NaF doses. After 30 days, euthanasia was performed; plasma and mitochondrial glutathione peroxidase (GPx) and catalase (CAT) activities and TBARS concentrations were measured as indexes of oxidative stress. In vitro, the effect of F 100 µM on the VO2 of liver slices and of isolated mitochondria was also evaluated. Finally, the addition of 100 µM of F on the activity of the respiratory chain complexes was assessed. Results are expressed as mean±SEM and differences were considered significant when p<0.05(*).

In vivo, VO2 (µmolO2/min.100g bw) decreased after 90 min of F dose in the NaF40 group (0min: 175.8±15.67, 90min: 156.0±16.62*). Plasma and mitochondrial TBARS levels and GPx and CAT activities were higher in the NaF-treated groups. In vitro, F caused a decrease in the VO2 by liver slices (nmolO2/min.mg prot) (0µM: 47±4.5; 100µM: 31±3.0*) and by mitochondria (nmolO2/min.mg prot) in state 4 (0µM: 55±5.0; 100µM: 29±3.5*) and in state 3 (0µM: 146±9.7; 100µM: 87±9.3*). The activity of complex I-III (µmol.min-1.mg prot-1) was also inhibited by F (without F: 1906±125; with F: 1720±71*).

Conclusions: F decreased VO2 in vivo after an oral dose, and the same effect was observed in vitro after the addition of F at similar plasma concentrations. The effect of F on VO2 is observed only with high values of fluoremias. F also decreased VO2 by isolated mitochondria. The oxidative stress increased in the treatment with NaF. This results support the hypothesis that the presence of bone inflammatory foci in NaF-treated rats, could be the consequence of an increase in ROS due to a modification of the respiratory chain activity.

 

Legal notice
  • Legal notice:
 

Related papers

Presentation: Oral at XXXth Conference of the International Society for Fluoride Research, by Brenda L. Fina
See On-line Journal of XXXth Conference of the International Society for Fluoride Research

Submitted: 2012-06-21 14:13
Revised:   2012-06-23 16:10